State opioid monitoring programs are not created equal

June 7, 2018, University of Michigan
Credit: University of Michigan

States that have struggled with opioid abuse might want to take a look at prescription drug monitoring programs in Kentucky, New Mexico, Tennessee and New York—states that have significantly reduced opioid dosages, according to a new University of Michigan study.

While most states currently have prescription drug programs, not all are created equal, says Rebecca Haffajee, assistant professor of health management policy at the U-M School of Public Health and lead author of a study that examines prescription drug monitoring programs in all 50 states.

The study, published in Health Affairs, shows that Kentucky, New Mexico, Tennessee and New York all have robust prescription drug monitoring programs that have significantly reduced dosages and the number of opioid fills. Kentucky has exhibited the most dramatic and consistent decreases along all outcomes—20-40 percent relative reductions in high opioid dosages (over 100 mg morphine milligram equivalents daily).

"For states that haven't implemented robust features and want to reduce the dosages of opioids prescribed, they might consider modeling their programs after some of these robust programs—particularly Kentucky's, because that's where we saw the greatest reductions," Haffajee said.

"But we would caution that any reductions in opioid prescriptions or dosages must be accompanied by careful clinical oversight—such as supervised tapers and referral to addiction treatment when indicated—so that patients don't suffer potential unintended consequences of reductions in their prescription opioid supply."

Haffajee and colleagues reviewed prescription drug monitoring program laws to identify states that had at least eight of 10 features that facilitate prescribers' access to comprehensive and timely data. These features included mandates that prescribers check the monitoring database, weekly updates of dispensing data, mandatory (or automated) registration for prescribers, and allowing prescribers to designate delegates to check the prescription drug monitoring program registry.

"We felt that that there was synergy between many of the program features, so to look at just one feature, as some studies have done, and then attribute any findings to that one feature seemed to be missing the overall picture of the programs," Haffajee said. "We thought it was important to look at the programs holistically."

After identifying Kentucky, New Mexico, Tennessee and New York as intervention states with robust programs, researchers selected neighboring comparison states that had similar outcome trends before the implementation of the programs. The study looked at adults with commercial insurance, who account for more than half of opioid prescriptions in many .

"Every state has a prescription drug monitoring program except for Missouri, but many still lack robust ," Haffajee said. "If a state implements a robust prescription monitoring , it will probably reduce the proportion of commercially insured adults who receive opioid prescriptions, as well as the strength of those ."

Other authors of the study included J. Frank Wharam and Fang Zhang, professors of population medicine at Harvard University and the Harvard Pilgrim Health Care Institute; Michelle Mello, professor of law and health research and policy at Stanford University; Alan Zaslavsky, professor of health care policy at Harvard; and Marc Larochelle, assistant professor of medicine at Boston Medical Center.

Explore further: Drug monitoring programs reduce opioid deaths, study finds

More information: Rebecca L. Haffajee et al. Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages, Health Affairs (2018). DOI: 10.1377/hlthaff.2017.1321

Related Stories

Drug monitoring programs reduce opioid deaths, study finds

June 22, 2016
The implementation of state prescription drug monitoring programs was associated with the prevention of approximately one opioid-related overdose death every two hours on average nationwide, according to a new Vanderbilt-led ...

Prescription drug monitoring programs may have negative unintended consequences

May 7, 2018
Prescription drug monitoring programs (PDMPs) are a key component of the President's Prescription Drug Abuse Prevention Plan and considered a critical tool for reducing prescription opioid-related illness and death. The results ...

Health policy researcher finds drug monitoring reduces opioid prescriptions, medicaid costs

April 4, 2017
UK College of Public Health researcher Hefei Wen has authored a study showing state drug-monitoring programs are effective in reducing the number of opioids prescribed to Medicaid recipients.

2 percent of opioid rx bought by 0.7 percent of patients

July 19, 2013
(HealthDay)—A small proportion of opioid prescription purchasers (0.7 percent) obtain an average of 32 prescriptions from 10 different prescribers, accounting for 1.9 percent of all opioid prescriptions, according to a ...

Marijuana legalization may reduce opioid use

April 4, 2018
(HealthDay)—State implementation of medical marijuana laws is associated with a reduction in the rate of opioid prescribing, according to a study published online April 2 in JAMA Internal Medicine.

New data: Americans filling far fewer opioid prescriptions

April 19, 2018
The number of prescriptions for opioid painkillers filled in the U.S. fell dramatically last year, showing their biggest drop in 25 years and continuing a decline amid increasing legal restrictions and public awareness of ...

Recommended for you

Study: What patients really think about opioid vs non-opioid medications for chronic pain

August 14, 2018
Prescriptions of opioids for chronic pain has increased dramatically since the 1990s in spite of their known harms. Despite a shortage of scientific studies on the long-term effectiveness of opioids such as morphine, oxycodone ...

Doctors nudged by overdose letter prescribe fewer opioids

August 9, 2018
In a novel experiment, doctors got a letter from the medical examiner's office telling them of their patient's fatal overdose. The response: They started prescribing fewer opioids.

Benzodiazepine and related drug prescriptions have increased among young people in Sweden

August 7, 2018
The prevalence rate of prescriptions for benzodiazepines and benzodiazepine-related drugs (BZD)—medications used to treat anxiety, insomnia, epilepsy and other neuropsychiatric conditions—increased by 22% between 2006 ...

Unwise opioids for wisdom teeth: Study shows link to long-term use in teens and young adults

August 7, 2018
Getting wisdom teeth removed may be a rite of passage for many teens and young adults, but the opioid painkiller prescriptions that many of them receive could set them on a path to long-term opioid use, a new study finds.

Behavioral nudges lead to striking drop in prescriptions of potent antipsychotic

August 1, 2018
A study led by Columbia University's Mailman School of Public Health has found that letters targeting high prescribers of Seroquel (quetiapine), an antipsychotic with potentially harmful side effects in the elderly, significantly ...

US opioid use not declined, despite focus on abuse and awareness of risk

August 1, 2018
Use of prescription opioids in the United States has not substantially declined over the last decade, despite increased attention to opioid abuse and awareness of their risks, finds a study published by The BMJ today.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.